Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Chintan J Dedhia"'
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 8, Iss C, Pp 58-61 (2017)
Purpose: To report the 12-month efficacy and safety outcomes of intravitreal ziv-aflibercept in macular edema secondary to central retinal vein occlusion (CRVO). Methods: Interventional case series documenting 12-month outcomes of intravitreal ziv-af
Externí odkaz:
https://doaj.org/article/5f2e2d5fcbc64cb690144c6cdc71cc45
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 8, Iss C, Pp 58-61 (2017)
American Journal of Ophthalmology Case Reports
American Journal of Ophthalmology Case Reports
Purpose To report the 12-month efficacy and safety outcomes of intravitreal ziv-aflibercept in macular edema secondary to central retinal vein occlusion (CRVO). Methods Interventional case series documenting 12-month outcomes of intravitreal ziv-afli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::145e3e25a9995a95929597618a8363ab
http://www.sciencedirect.com/science/article/pii/S2451993617300336
http://www.sciencedirect.com/science/article/pii/S2451993617300336
Autor:
Imoro Zeba, Braimah, Michael, Stewart, Chetan, Videkar, Chintan J, Dedhia, Jay, Chhablani, Komal, Agrawal
Publikováno v:
British Journal of Ophthalmology. 101:1201-1205
Aim To report the short-term outcomes of eyes with choroidal neovascularisation (CNV) associated with causes other than age-related macular degeneration (AMD) after treatment with intravitreal ziv-aflibercept (IVZ) injections. Methods This retrospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::499928531ab949f255aa21757aaccd53
https://doi.org/10.1136/bjophthalmol-2016-309994
https://doi.org/10.1136/bjophthalmol-2016-309994
Autor:
Abdulrazzak Charbaji, Jay Chhablani, Ahmad M. Mansour, Chintan J Dedhia, Ahmed Souka, Mohammed Ashraf
Publikováno v:
British Journal of Ophthalmology. 101:1374-1376
To investigate the long-term safety of intravitreal ziv-aflibercept in eyes receiving six or more intravitreal injections of ziv-aflibercept, an off-label substitute to the approved aflibercept.Consecutive patients with retinal disease receiving six
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88bc246d7c006689a7bcbf2f001f7d9a
https://doi.org/10.1136/bjophthalmol-2016-309724
https://doi.org/10.1136/bjophthalmol-2016-309724
Publikováno v:
Acta ophthalmologica. 96(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24cb9ccaf33ed703fe024e51e111df54
https://pubmed.ncbi.nlm.nih.gov/28371171
https://pubmed.ncbi.nlm.nih.gov/28371171
Publikováno v:
Retina (Philadelphia, Pa.). 37(10)
Purpose To evaluate the safety of single intravitreal 2 mg ziv-aflibercept (0.08 mL) injections for the treatment of choroidal neovascular membranes (CNVM). Methods Eyes with choroidal neovascular membranes because of several conditions each received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49a4d905f7ffb31ff5b983a0f0840d35
https://pubmed.ncbi.nlm.nih.gov/28060148
https://pubmed.ncbi.nlm.nih.gov/28060148
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Remya Paulose,1 Jay Chhablani,1 Chintan J Dedhia,1 Michael W Stewart,2 Ahmad M Mansour3,4 1Smt. Kanuri Santhamma Centre for Vitreoretinal Diseases, LV Prasad Eye Institute, Hyderabad, India; 2Department of Ophthalmology, Mayo Clinic, Jacksonville, FL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db01f788776cbb0f5167739d621a8997
https://www.dovepress.com/intravitreal-ziv-aflibercept-for-macular-edema-following-retinal-vein--peer-reviewed-article-OPTH
https://www.dovepress.com/intravitreal-ziv-aflibercept-for-macular-edema-following-retinal-vein--peer-reviewed-article-OPTH
Publikováno v:
The British journal of ophthalmology. 101(2)
Purpose We report the 3-month efficacy of monthly intravitreal ziv-aflibercept in patients with diabetic macular oedema (DME). Methods Prospectively, consecutive patients with DME underwent intravitreal injection of 0.05 ml of compounded ziv-afliberc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8663c1cb1862fe3148bfed8bd8241cde
https://pubmed.ncbi.nlm.nih.gov/27190127
https://pubmed.ncbi.nlm.nih.gov/27190127